Donald R. Gehlert
Mail Code 0510
Lilly Research Laboratories
Eli Lilly and Company
Lilly Corporate Center
Name/email consistency: high
- Effects of corticotropin-releasing factor 1 receptor antagonism on the hypothalamic-pituitary-adrenal axis of rodents. Gehlert, D.R., Cramer, J., Morin, S.M. J. Pharmacol. Exp. Ther. (2012)
- Preclinical evaluation of melanin-concentrating hormone receptor 1 antagonism for the treatment of obesity and depression. Gehlert, D.R., Rasmussen, K., Shaw, J., Li, X., Ardayfio, P., Craft, L., Coskun, T., Zhang, H.Y., Chen, Y., Witkin, J.M. J. Pharmacol. Exp. Ther. (2009)
- Monoaminergic compensation in the neuropeptide Y deficient mouse brain. Gehlert, D.R., Thompson, L.K., Hemrick-Luecke, S.K., Shaw, J. Neuropeptides (2008)
- Co-expression of neuropeptide Y Y1 and Y5 receptors results in heterodimerization and altered functional properties. Gehlert, D.R., Schober, D.A., Morin, M., Berglund, M.M. Biochem. Pharmacol. (2007)
- Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function. Gehlert, D.R., Shaw, J.L. Peptides (2007)
- Distribution of nociceptin and Ro64-6198 activated [35S]-GTPgammaS binding in the rat brain. Gehlert, D.R., Gackenheimer, S.L., Shaw, J.L. Neuropeptides (2006)
- Stress and central Urocortin increase anxiety-like behavior in the social interaction test via the CRF1 receptor. Gehlert, D.R., Shekhar, A., Morin, S.M., Hipskind, P.A., Zink, C., Gackenheimer, S.L., Shaw, J., Fitz, S.D., Sajdyk, T.J. Eur. J. Pharmacol. (2005)
- Introduction to the reviews on neuropeptide Y. Gehlert, D.R. Neuropeptides (2004)
- Cloning and characterization of Rhesus monkey neuropeptide Y receptor subtypes. Gehlert, D.R., Yang, P., George, C., Wang, Y., Schober, D., Gackenheimer, S., Johnson, D., Beavers, L.S., Gadski, R.A., Baez, M. Peptides (2001)
- Role of hypothalamic neuropeptide Y in feeding and obesity. Gehlert, D.R. Neuropeptides (1999)
- Multiple receptors for the pancreatic polypeptide (PP-fold) family: physiological implications. Gehlert, D.R. Proc. Soc. Exp. Biol. Med. (1998)
- Neuropeptide Y receptor antagonists in obesity. Gehlert, D.R., Hipskind, P.A. Expert. Opin. Investig. Drugs (1997)
- [125I]Leu31, Pro34-PYY is a high affinity radioligand for rat PP1/Y4 and Y1 receptors: evidence for heterogeneity in pancreatic polypeptide receptors. Gehlert, D.R., Schober, D.A., Gackenheimer, S.L., Beavers, L., Gadski, R., Lundell, I., Larhammar, D. Peptides (1997)
- Characterization of the peptide binding requirements for the cloned human pancreatic polypeptide-preferring receptor. Gehlert, D.R., Schober, D.A., Beavers, L., Gadski, R., Hoffman, J.A., Smiley, D.L., Chance, R.E., Lundell, I., Larhammar, D. Mol. Pharmacol. (1996)
- The neuropeptide Y Y1 receptor selective radioligand, [125I][Leu31,Pro34]peptide YY, is also a high affinity radioligand for human pancreatic polypeptide 1 receptors. Gehlert, D.R., Gackenheimer, S.L., Schober, D.A., Beavers, L., Gadski, R., Burnett, J.P., Mayne, N., Lundell, I., Larhammar, D. Eur. J. Pharmacol. (1996)
